osaühing KBM PharmaRegistered
Key figures
4 603 056 €+5,6%
Revenue 2025
+10,0%
Average annual growth 2019–2025
Ratios
20255,8%
Profit margin
7,4%
EBITDA margin
64,1%
Equity ratio
2,5×
Current ratio
15,9%
Return on equity
3155 €
Average gross salary
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q2 2026 | 1 684 022 € | 16 | 82 848 € |
| Q1 2026 | 2 436 363 € | 16 | 80 726 € |
| Q4 2025 | 2 099 504 € | 16 | 82 373 € |
| Q3 2025 | 1 847 437 € | 15 | 84 544 € |
| Q2 2025 | 1 447 083 € | 16 | 84 771 € |
| Q1 2025 | 2 258 482 € | 15 | 71 458 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Dividends
calculated2025
Distributed as dividends 300 000 € (18% of distributable profit).
History
2025300 000 €
2024300 000 €
2023500 000 €
2022200 001 €
2021150 000 €
2020150 000 €
Previous year's retained earnings + previous year's profit − current retained earnings.
Summary of financial statements2019–2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||
| Total current assets | 1 141 753 | 1 364 981 | 1 523 960 | 2 271 450 | 2 318 243 | 2 172 568 | 2 370 787 |
| Total non-current assets | 185 751 | 170 875 | 170 502 | 256 923 | 244 626 | 239 523 | 242 009 |
| Total assets | 1 327 504 | 1 535 856 | 1 694 462 | 2 528 373 | 2 562 869 | 2 412 091 | 2 612 796 |
| Balance sheet — liabilities and equity | |||||||
| Current liabilities | 587 294 | 611 950 | 607 197 | 921 362 | 889 966 | 703 094 | 937 423 |
| Non-current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | 587 294 | 611 950 | 607 197 | 921 362 | 889 966 | 703 094 | 937 423 |
| Share capital | 6350 | 6350 | 6350 | 6350 | 6350 | 6350 | 6350 |
| Retained earnings of previous periods | 523 265 | 583 221 | 766 917 | 880 275 | 1 100 022 | 1 365 914 | 1 402 008 |
| Profit for the year | 209 956 | 333 696 | 313 359 | 719 747 | 565 892 | 336 094 | 266 376 |
| Reserves and other equity | 639 | 639 | 639 | 639 | 639 | 639 | 639 |
| Total equity | 740 210 | 923 906 | 1 087 265 | 1 607 011 | 1 672 903 | 1 708 997 | 1 675 373 |
| Income statement | |||||||
| Sales revenue | 2 599 163 | 2 678 485 | 3 052 928 | 3 889 672 | 4 265 554 | 4 359 664 | 4 603 056 |
| Operating profit | 248 877 | 371 105 | 350 594 | 770 396 | 684 498 | 390 858 | 338 374 |
| EBITDA | 270 494 | 385 980 | 365 470 | 785 272 | 699 374 | 405 734 | 341 439 |
| Profit before income tax | 246 596 | 369 532 | 348 392 | 767 280 | 688 081 | 406 849 | 350 991 |
| Profit for the reporting year | 209 956 | 333 696 | 313 359 | 719 747 | 565 892 | 336 094 | 266 376 |
| Labour costs | 429 291 | 429 135 | 472 945 | 505 275 | 625 073 | 648 364 | 723 802 |
| Depreciation of non-current assets | 21 617 | 14 875 | 14 876 | 14 876 | 14 876 | 14 876 | 3065 |
| Other indicators | |||||||
| Employees | 14 | 14 | 15 | 16 | 16 | 15 | 15 |
| Calculated dividend | — | 150 000 | 150 000 | 200 001 | 500 000 | 300 000 | 300 000 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
CompanyPersonShareholderOther roleAdditional link
Related companies
Same activity — Ravimite ja muude apteegikaupade hulgimüük